Glenmark zooms 9% on DCGI nod to conduct clinical trials for Covid-19 drug
Glenmark is the first pharma company in India to be given an approval by the regulator to start the trial on COVID-19 patients
Glenmark is the first pharma company in India to be given an approval by the regulator to start the trial on COVID-19 patients https://ift.tt/2WeRiBd April 29, 2020 at 06:14PM
Glenmark is the first pharma company in India to be given an approval by the regulator to start the trial on COVID-19 patients https://ift.tt/2WeRiBd April 29, 2020 at 06:14PM
Comments
Post a Comment